Որոնման արդյունքները - Katharina Modelska
- Ցուցադրվում են 1 - 6 արդյունքները 6
-
1
-
2
Roxadustat versus placebo for patients with lower‐risk myelodysplastic syndrome: MATTERHORN phase 3, double‐blind, randomized controlled trial Moshe Mittelman, David H. Henry, John A. Glaspy, Anıl Tombak, Rosemary Harrup, Inho Kim, Krzysztof Mądry, Barbara Grabowska, Tyson Lee, Katharina Modelska
Հրապարակվել է 2024Artigo -
3
Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer Maha Hussain, Karim Fizazi, Fred Saad, Per Rathenborg, Neal D. Shore, Ubirajara Ferreira, Petro Ivashchenko, Eren Demirhan, Katharina Modelska, De Phung, Andrew Krivoshik, Cora N. Sternberg
Հրապարակվել է 2018Artigo -
4
Roxadustat for the treatment of anemia in patients with <scp>lower‐risk</scp> myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study David H. Henry, John A. Glaspy, Rosemary Harrup, Moshe Mittelman, Amy Zhou, Hetty E. Carraway, Charles W. Bradley, Gopal Saha, Katharina Modelska, Pamela Bartels, Robert Leong, Kin‐Hung P. Yu
Հրապարակվել է 2021Artigo -
5
A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic (M0) castration-resistant prostate cancer (CRPC): Results of... Karim Fizazi, Maha Hussain, Fred Saad, Neal D. Shore, Ugo De Giorgi, Eleni Efstathiou, Ubirajara Ferreira, Petro Ivashchenko, Katarzyna Madziarska, Mohammed Al-Adhami, Katharina Modelska, D. Phung, Joyce Steinberg, Cora N. Sternberg
Հրապարակվել է 2018Artigo -
6
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer Cora N. Sternberg, Karim Fizazi, Fred Saad, Neal D. Shore, Ugo De Giorgi, David F. Penson, Ubirajara Ferreira, Eleni Efstathiou, Katarzyna Madziarska, Michael Paul Kolinsky, Daniel de Iracema Gomes Cubero, Bettina Noerby, Fabian Zohren, Xun Lin, Katharina Modelska, Jennifer Sugg, Joyce Steinberg, Maha Hussain
Հրապարակվել է 2020Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Internal medicine
Medicine
Oncology
Androgen receptor
Cancer
Enzalutamide
Prostate cancer
Urology
Alternative medicine
Anemia
Biochemistry
Bone marrow
Chemistry
Clinical endpoint
Hormone
Myelodysplastic syndromes
Pathology
Placebo
Randomized controlled trial
Androgen deprivation therapy
Artificial intelligence
Biology
Castration
Clinical trial
Computer science
Doubling time
Endocrinology
Enzyme
Gynecology
In vitro